Altshuler Shaham’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Altshuler Shaham’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-319	Closed	-$25K	–	556
2022 Q2	$25K	Buy	+319	New	+$30.2K	﹤0.01%	377
2021 Q1	–	Sell	-627	Closed	-$46K	–	563
2020 Q4	$46K	Sell	627 -466	-43%	-$34.6K	﹤0.01%	275
2020 Q3	$85K	Buy	1,093 +692	+173%	+$47.6K	﹤0.01%	189
2020 Q2	$22K	Buy	401 +15	+4%	+$642	﹤0.01%	254
2020 Q1	$11K	Buy	+386	New	+$13.1K	﹤0.01%	295

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Altshuler Shaham's HZNP Position: Q3 2022 in Review

Altshuler Shaham sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q3 2022, closing a stake of 319 shares — an estimated $25K sold.

Altshuler Shaham first reported a position in HZNP in Q1 2020 and held it in 5 quarters. The position peaked at $85K in Q3 2020. 530 funds tracked by Wall St. Rank hold HZNP as of Q3 2022.

Altshuler Shaham reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q3 2022 after selling out during the quarter.
Altshuler Shaham sold 319 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q3 2022, an estimated $25K.
Altshuler Shaham first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2020 and held it in 5 quarters.
Altshuler Shaham's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $85K in Q3 2020.
530 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q3 2022.

Based on Altshuler Shaham's 13F filing for Q3 2022, filed 14 Nov 2022.